Vamorolone clinical trials

Expanded Access Protocol for Boys With Duchenne Muscular Dystrophy

This program helps boys with Duchenne muscular dystrophy in Canada continue to receive a medicine called vamorolone. It's for those who have already been in earlier studies, allowing them to keep taking the medication while it awaits wider approval. It is not currently looking for new participants.